Expected time commitment?
3-5 minutes minimum. You can participate as much or as little as you like, but we encourage you to return to the conversation at least 2-3 times to see how the conversation evolves. It's a nice time filler you can do on your phone.
Over 5,500 votes have been cast on statements like:
- Development of new melanoma medicines should be prioritised over research into de-intensification
- Everyone, regardless of age, should be offered de-intensified treatment options
- Fear of being overtreated is real
Who can participate?
Anyone living in Australia with melanoma (stage II-IV), their carers, and Australian healthcare professionals are invited to participate. You don't have to be a specialist in melanoma - allied health, nursing, GP, pall care, onc, surg, derm colleagues welcome
The Oxford comma (also known as the 'serial comma') is the comma that separates the second to last item in a list from a final item that is introduced by 'and' or 'or.'
It is optional...but be aware that not using the serial comma can result in some ambiguity.
Calling Australian Oncologists at MOGA and beyond! Contribute your perspectives on the time toxicity of palliative systemic treatments by taking our 10 minute survey - more in the poster hall at #MOGA24@MOGA_ORG
Follow the link to participate: https://t.co/58W14tOLEi
I am deeply honoured to have been awarded the Morgan Mansell Young Melanoma Researcher of the Year, in recognition of Morgan, an incredible human who faced unimaginable health challenges.
Congratulations to Dr Jennifer Soon @drjnnsoon, the 2023 Morgan Mansell Young Melanoma Researcher of the Year. Congrats also to the other two finalists Dr Emma Bawden and Dr Deval Mehta. Excellent presentations by all. Such a highlight of MRVs annual Meeting.
You can read more about Morgan's story at her blog here: https://t.co/85ctD0cP5u. And our research paper here: https://t.co/RpvqAbCSJx
(I'm almost equally thrilled to still be considered "young"!)
💰 The rising cost of #cancer treatment places immense pressure on those who bear the price.
💊 @drjnnsoon from @ServicesCancer explores how a new prioritisation technique called #HorizonScanning can provide equitable access to life-saving medicines.
👉 https://t.co/p7uVLIoVrK
Our new study is out today in The BMJ @bmj_latest!
Can receiving drug industry money lead oncologists to provide WORSE care?
The answer we found appears to be “yes”…
🧵 to follow
1/
https://t.co/xpYpbUiklg
There's been criticism from some (*cough* @CancerEthicsDoc *cough*) about my lack of #MOGA23 conf content. I'll argue it's been covered well enough by others, incl @SamuelXStevens and @DKarikios. Absolute pleasure to meet the above F2F after hearing so much about their work 1/2
Obvious conference highlight: meeting @oncology_bg and catching up with old work colleagues @DrChloeG, Hayley R and Arielle VM. The real lowlight was realising I can't sleep without my snoring husband next to me and unweaned toddler attached to me. 2/2